|
|
|
|
|
|
|
Amicus Therapeutics Inc. (FOLD)
|
|
11.97 -0.32 (-2.6%)
|
10-19 16:00
|
|
Open:
|
12.3
|
Pre. Close:
|
12.29
|
|
High:
|
12.65
|
Low:
|
11.93
|
|
Volume:
|
2,085,388
|
Market Cap:
|
2264M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
12.655 - 12.741
|
12.741 - 12.811
|
|
Low:
|
11.773 - 11.853
|
11.853 - 11.919
|
|
Close:
|
11.853 - 11.983
|
11.983 - 12.09
|
|
|
|
Technical analysis (as of: 2018-10-19 4:35:05 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 15.26 One year: 16.32
|
|
Support:
|
Support1: 11.60 Support2: 9.65
|
|
Resistance:
|
Resistance1:
13.06 Resistance2: 13.97
|
|
Pivot:
|
12.60
|
|
Moving Averages:
|
MA(5): 12.40 MA(20): 12.53
MA(100): 14.26 MA(250): 14.39
|
|
MACD:
|
MACD(12,26):
-0.12 Signal(12,26,9): -0.11
|
|
%K %D:
|
%K(14,3): 32.35 %D(3): 39.19
|
|
RSI:
|
RSI(14): 44.06
|
|
52-Week:
|
High: 17.62
Low: 11.57 Change(%): -9.8
|
|
Average Vol(K):
|
3-Month: 250366
10-Days 242749
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.FOLD has closed above bottom band by 19.3%. Bollinger Bands are 5.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-10-08T11:50:12-04:00
Daily Insider Ratings Round-Up 10/5/18
2018-10-08T08:03:06-04:00
Amicus Therapeutics collaborates with University of Pennsylvania to develop AAV gene therapies
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
